Results 141 to 146 of about 3,785 (146)

Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host Disease of the Gastrointestinal Tract

Biology of Blood and Marrow Transplantation, 2006
Drew J Winston, Lindsey R Baden, Christos Emmanouilides   +2 more
exaly  

Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009–2015

Clinical Therapeutics, 2018
Jessica Leung, Sheila C Dollard, Scott D Grosse   +2 more
exaly  

A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients

American Journal of Transplantation, 2009
Amparo Sole, Joan Gavalda, Piedad Ussetti   +2 more
exaly  

Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir

Clinical Infectious Diseases
Martha Fournier, Jingyang Wu, Dominik Selleslag   +2 more
exaly  

Reactivity of Valganciclovir in Aqueous Solution

Drug Development and Industrial Pharmacy, 2005
exaly  

Valganciclovir: An Advance in Cytomegalovirus Therapeutics

Annals of Pharmacotherapy, 2002
exaly